Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Bayesian Applications in Auditory Research.

McMillan GP, Cannon JB.

J Speech Lang Hear Res. 2019 Mar 25;62(3):577-586. doi: 10.1044/2018_JSLHR-H-ASTM-18-0228.

PMID:
30950731
2.

Global estimates of mortality associated with long-term exposure to outdoor fine particulate matter.

Burnett R, Chen H, Szyszkowicz M, Fann N, Hubbell B, Pope CA 3rd, Apte JS, Brauer M, Cohen A, Weichenthal S, Coggins J, Di Q, Brunekreef B, Frostad J, Lim SS, Kan H, Walker KD, Thurston GD, Hayes RB, Lim CC, Turner MC, Jerrett M, Krewski D, Gapstur SM, Diver WR, Ostro B, Goldberg D, Crouse DL, Martin RV, Peters P, Pinault L, Tjepkema M, van Donkelaar A, Villeneuve PJ, Miller AB, Yin P, Zhou M, Wang L, Janssen NAH, Marra M, Atkinson RW, Tsang H, Quoc Thach T, Cannon JB, Allen RT, Hart JE, Laden F, Cesaroni G, Forastiere F, Weinmayr G, Jaensch A, Nagel G, Concin H, Spadaro JV.

Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):9592-9597. doi: 10.1073/pnas.1803222115. Epub 2018 Sep 4.

3.

Short-Term Elevation of Fine Particulate Matter Air Pollution and Acute Lower Respiratory Infection.

Horne BD, Joy EA, Hofmann MG, Gesteland PH, Cannon JB, Lefler JS, Blagev DP, Korgenski EK, Torosyan N, Hansen GI, Kartchner D, Pope CA 3rd.

Am J Respir Crit Care Med. 2018 Sep 15;198(6):759-766. doi: 10.1164/rccm.201709-1883OC.

PMID:
29652174
4.

Return on investment from fuel treatments to reduce severe wildfire and erosion in a watershed investment program in Colorado.

Jones KW, Cannon JB, Saavedra FA, Kampf SK, Addington RN, Cheng AS, MacDonald LH, Wilson C, Wolk B.

J Environ Manage. 2017 Aug 1;198(Pt 2):66-77. doi: 10.1016/j.jenvman.2017.05.023. Epub 2017 May 11.

PMID:
28501609
5.

Short-Term Exposure to Fine Particulate Matter Air Pollution Is Preferentially Associated With the Risk of ST-Segment Elevation Acute Coronary Events.

Pope CA, Muhlestein JB, Anderson JL, Cannon JB, Hales NM, Meredith KG, Le V, Horne BD.

J Am Heart Assoc. 2015 Dec 8;4(12). pii: e002506. doi: 10.1161/JAHA.115.002506.

6.

Microarrays and microneedle arrays for delivery of peptides, proteins, vaccines and other applications.

Chandrasekhar S, Iyer LK, Panchal JP, Topp EM, Cannon JB, Ranade VV.

Expert Opin Drug Deliv. 2013 Aug;10(8):1155-70. doi: 10.1517/17425247.2013.797405. Epub 2013 May 11. Review.

PMID:
23662940
7.

Do natural disturbances or the forestry practices that follow them convert forests to early-successional communities?

Brewer JS, Bertz CA, Cannon JB, Chesser JD, Maynard EE.

Ecol Appl. 2012 Mar;22(2):442-58.

PMID:
22611846
8.

Recent advances in prodrugs as drug delivery systems.

Lin C, Sunkara G, Cannon JB, Ranade V.

Am J Ther. 2012 Jan;19(1):33-43. doi: 10.1097/MJT.0b013e3181f47f3f.

PMID:
21150770
9.

Preventing illegal tobacco and alcohol sales to minors through electronic age-verification devices: a field effectiveness study.

Krevor B, Capitman JA, Oblak L, Cannon JB, Ruwe M.

J Public Health Policy. 2003;24(3-4):251-68.

PMID:
15015859
10.

Effects of chronic cocaine on monoamine levels in discrete brain structures of lactating rat dams.

Lubin DA, Cannon JB, Black MC, Brown LE, Johns JM.

Pharmacol Biochem Behav. 2003 Jan;74(2):449-54.

11.

Alternate drug delivery routes for A-71623, a potent cholecystokinin-A receptor agonist tetrapeptide.

Cannon JB, Adjei LA, Lu MY, Garren K.

J Drug Target. 1996;4(2):69-78.

PMID:
8894966
12.

Physicochemical properties of A-75998, an antagonist of luteinizing hormone releasing hormone.

Cannon JB, Krill SL, Porter WR.

J Pharm Sci. 1995 Aug;84(8):953-8.

PMID:
7500280
13.

Oak Ridge's Strengths.

Cannon JB.

Science. 1995 Jun 9;268(5216):1417. No abstract available.

PMID:
17843643
14.

The effect of aggregation inhibitors and antioxidants on the stability of hemin solutions.

Cannon JB, Yunker MH, Luoma N.

PDA J Pharm Sci Technol. 1995 Mar-Apr;49(2):77-82.

PMID:
7780749
15.

Pharmaceutics and drug delivery aspects of heme and porphyrin therapy.

Cannon JB.

J Pharm Sci. 1993 May;82(5):435-46. Review.

PMID:
8360819
16.

Targeted delivery of a heme oxygenase inhibitor with a lyophilized liposomal tin mesoporphyrin formulation.

Cannon JB, Martin C, Drummond GS, Kappas A.

Pharm Res. 1993 May;10(5):715-21.

PMID:
8321837
17.

Immunoconjugates in drug delivery systems.

Cannon JB, Hui HW.

Targeted Diagn Ther. 1990;3:121-39. Review. No abstract available.

PMID:
2131008
18.

The effect of metalloporphyrins and heme liposomes on delta-aminolevulinate synthase activity in rat liver.

Cannon JB, Kuo FS, Vatandoust F, Liem HH, Muller-Eberhard U.

Biochem Biophys Res Commun. 1985 Jul 16;130(1):306-12.

PMID:
4026834
19.

Kinetics of the interaction of hemin liposomes with heme binding proteins.

Cannon JB, Kuo FS, Pasternack RF, Wong NM, Muller-Eberhard U.

Biochemistry. 1984 Jul 31;23(16):3715-21.

PMID:
6089878
20.

Aluminum pots as a source of dietary aluminum.

Trapp JA, Cannon JB.

N Engl J Med. 1981 Jan 15;304(3):172. No abstract available.

PMID:
7442738
22.

The effect of phospholipid vesicles on the kinetics of reduction of cytochrome c.

Cannon JB, Erman JE.

Biochem Biophys Res Commun. 1978 Sep 14;84(1):254-60. No abstract available.

PMID:
215140

Supplemental Content

Loading ...
Support Center